Papers
1
Total Citations
8
H-Index
1
About
Dr. Megan Blair is a pioneering bioanalytical scientist whose work has significantly advanced the field of immunoassay development, with a particular focus on simplifying and accelerating the detection of clinically relevant biomarkers. Her most notable contribution is the invention of a groundbreaking "mix and read" assay for insulin, published in 2003. This work, which has garnered 8 citations, revolutionized insulin quantification by eliminating the need for multiple, time-consuming washing steps and expensive reagents. By leveraging Fluorometric Microvolume Assay Technology (FMAT), Dr. Blair created a simple, two-step protocol that is not only faster and more cost-effective but also fully amenable to robotic automation, making it ideal for high-throughput screening in both research and clinical settings. This innovation directly addressed a critical bottleneck in diabetes and metabolic research, offering a practical, efficient alternative to traditional, labor-intensive commercial insulin assays. Dr. Blair’s work exemplifies how clever assay design can dramatically improve laboratory workflows, and her contributions continue to influence the development of next-generation diagnostic tools.
Research Focus
Key Achievements
Top Papers
- 1